Antisense IGF-I for Hepatocellular Carcinoma

互联网2014-02-13

668

Antisense gene therapy involves the selective inhibition of expression or function of disease-causing genes by treatment with an antisense molecules (RNA or oligodeoxynucleotides) complementary to its target nucleic acids, usually to some specific mRNA molecules or mRNA precursor molecules, at a specific site (1 ,2 ) (see also Note 1 ).

相关产品推荐

CD24/CD24蛋白/(Small cell lung carcinoma cluster 4 antigen) (CD24A)蛋白/Recombinant Human Signal transducer CD24 (CD24)-Nanoparticle (Active)重组蛋白

￥69

Human IGF-1 ELISA Kit（人胰岛素样生长因子1 ELISA试剂盒）

￥1600

KAAG1/KAAG1蛋白Recombinant Human Kidney-associated antigen 1 (KAAG1)重组蛋白RU2 antisense gene protein蛋白

￥2640

CA9/CA9蛋白/Carbonate dehydratase IXCarbonic anhydrase IX ;CA-IX ;CAIXMembrane antigen MNP54/58NRenal cell carcinoma-associated antigen G250 ;R;CC-associated antigen G250pMW1蛋白/Recombinant Human Carbonic anhydrase 9 (CA9), partial重组蛋白

￥69

RETNLB/RETNLB蛋白/Colon and small intestine-specific cysteine-rich protein Colon carcinoma-related gene protein Cysteine-rich secreted protein A12-alpha-like 1 Cysteine-rich secreted protein FIZZ2 RELMbeta蛋白/Recombinant Human Resistin-like beta (RETNLB)重组蛋白

￥69